Clinical trial

To Evaluate the Safety and Efficacy of RP902 Tablets

NCT07579884

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-07-14

PhasePHASE2

Study timeline

Study start (actual)2026-07-14Date precision: day

Registry last updated2026-10-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Mild Cognitive Impairment (MCI)unresolved

Interventions

RP902DRUG

PlaceboDRUG

Sponsors & collaborators

Risen (Suzhou) Pharma Tech Co., Ltd.lead sponsor

Mapped research locations

BeijingBeijing Municipality, China2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07579884 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.